Skip to main content
Fig. 4 | BMC Genomics

Fig. 4

From: Transcriptomic analysis of marine endophytic fungi extract identifies highly enriched anti-fungal fractions targeting cancer pathways in HepG2 cell lines

Fig. 4

Inhibition of proliferation of HepG2 cells by the three partially purified fractions from the MEF 134 crude extracts. a Representative light microscopy images of HepG2 cells treated with the MEF 134 fractions. The dose of each fraction used for the assay is indicated in percentages (w/v). b-d Quantification of the anti-proliferative effect of the fractions. The fractions used for the assay were FD K1V1V1 (V1), FD K1V5V3 (V3) and FD K2V3V5 (V5). All measurements were performed in biological duplicates. All three fractions had antifungal activity against S. cerevisiae only

Back to article page